MSSANT Network Winter 15 WEB NEW 220615
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
A message from the General Manager<br />
– Client Services Sue Shapland<br />
“Those who can adapt to change are<br />
those who will continue to grow,”<br />
Justin Ramalho<br />
Well never a truer word spoken and very pertinent at this<br />
time! Change is the one constant and we are experiencing<br />
ongoing change across the board currently.<br />
In the MS world there are three new therapies available<br />
and additional international research efforts focusing on<br />
progressive MS.<br />
Of course the biggest and most significant changes that will<br />
come about will relate to the evaluation of the various NDIS<br />
trial sites and how the model will look and be rolled out.<br />
However the scheme ultimately looks, the outcomes for<br />
people who do, or may need a wide range of supports or<br />
equipment will be so much better under these changes.<br />
Already in WA we are seeing some of our Members within<br />
both of the trial sites accessing their new individual funding<br />
plans to their benefit.<br />
We are looking forward to plotting our new directions for<br />
<strong>MSSANT</strong>; expanding our capacity to support people living<br />
with MS. We will keep you posted with information and<br />
updates as they come to hand.<br />
I would like to thank everyone who took the time to provide<br />
us with their feedback through our first annual Client<br />
Services Survey. We are currently finalising the results and<br />
will be happy to share these with you in the next <strong>Network</strong>.<br />
Don’t forget flu season is on the way. Have you had your flu<br />
jab? We have added some tips on trying to avoid the flu in<br />
this edition.<br />
Please remember the Client Services team, including<br />
Amy on our MS Assist line, are here to provide you with<br />
quality information about all aspects of MS, treatments,<br />
research and support.<br />
Secondary Progressive<br />
MS Study<br />
• Are you aged 18 – 65 years?<br />
• Have you been diagnosed with<br />
Secondary Progressive Multiple Sclerosis (SPMS)?<br />
• Are you interested in a study investigating<br />
the efficacy of a new medication for SPMS?<br />
If you’ve said yes to any of the above,<br />
then you may be eligible to participate.<br />
For further information please call PARC on 8222 2712<br />
This study has been approved by<br />
the Royal Adelaide Hospital Human<br />
Research Ethics Committee<br />
The MS Society of South Australia & Northern Territory <strong>Winter</strong> 20<strong>15</strong> 5